Purpose | Announcement Date | Ex-Date | Record Date | Dividend Amount | Dividend per Share | Remark |
---|---|---|---|---|---|---|
Dividend | 20 Feb 2025 | 17 Apr 2025 | 17 Apr 2025 | 55 | 550 | Final |
We refer to our letter dated 14th February 2025, informing you of our Board Meeting that was scheduled today. In this regard, we wish to inform you that pursuant to Regulation 30 and 33 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 the Board of Directors at its meeting held today i.e., Thursday, 20th February 2025, Approved the Audited Standalone Financial Statements of the Company for the Quarter and Financial Year ended 31st December 2024. Accordingly, we enclose a copy of the Audited Standalone Financial Statements and Auditors Report for the Financial Year ended 31st December, 2024 along with Statement of Assets and Liabilities as on that date and Standalone Statement of Cashflows for the year ended 31st December, 2024. Sanofi Consumer Healthcare India Limited has informed the Exchange that the Record date for the purpose of Dividend is 28th April 2025. (As Per BSE Announcement Dated on: 04/03/2025) Intimation for change in Record Date for Dividend (As Per Bse Announcement Dated on 09.04.2025) |
The company faced headwinds in the December 2024 quarter (Q4) as it reported a significant decline in earnings.
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.